Imerys

AGM Information • May 10, 2019

PARIS, MAY 10, 2019

Ordinary & Extraordinary Shareholders' General Meeting of May 10, 2019

Imerys Shareholders' General Meeting held today in Paris and chaired by Gilles Michel, Chairman of the Board, approved all the resolutions presented by the Board of Directors.

➢ APPROVAL OF 2018 FINANCIAL STATEMENTS

In particular, the Shareholders' General Meeting approved the statutory and consolidated financial statements for 2018, which report a net income from current operations, Group share, of €356,8 million, up + 6.5% compared with financial year 2017.

➢ DIVIDEND

The Shareholders' General Meeting decided to distribute a €2.15 dividend per share, representing an increase of + 3.6% compared with financial year 2017. This dividend will be paid out as from May 22, 2019.

➢ GOVERNANCE

The Shareholders' General Meeting also approved:

• the compensation policy of the executive corporate officers for 2019 and the components of the compensation as well as benefits of all kinds due or awarded for financial year 2018 to Gilles Michel, as Chairman and Chief Executive Officer and then Chairman, and Conrad Keijzer, as Deputy Chief Executive Officer and then Chief Executive Officer;
• the renewal of the term of office as Directors (3 years) of Odile Desforges, Ian Gallienne and Lucile Ribot.

Therefore, the Board of Directors is comprised, as of today, of 14 members, including 2 employee representative directors, 6 independent members (i.e. 50% of the Board) and 5 women (i.e. 41.67% of the Board, excluding the employee representative directors) and one non-voting member (censeur).

➢ FINANCIAL AUTHORIZATIONS

The Ordinary & Extraordinary Shareholders' Meeting also approved the renewal, in favor of the Board of Directors, of the authorization for the Company to buy back its own shares as well as the whole set of traditional financial authorizations to increase the share capital, with or without preemptive subscription rights for existing shareholders.

Voting results per resolution as well as the presentation of the Shareholders' General Meeting are available on the Company's website www.imerys.com. The compensation components of the executive corporate officers are also publicly published on the Company's website as in accordance with the AFEP-MEDEF Governance Code.

Financial agenda 2019

June 13, 2019	Capital Market Day
July 25, 2019 (post market)	H1 2019 Results
October 29, 2019 (post market)	Q3 2019 Results

These dates are tentative and may be updated on the Group's website at www.imerys.com, in the Investors & Analysts / Financial Agenda section.

The world leader in mineral-based specialty solutions for industry, with €4.6 billion revenue and 18,000 employees, Imerys delivers high value-added, functional solutions to a great number of sectors, from processing industries to consumer goods. The Group draws on its knowledge of applications, technological expertise and its material science know-how to deliver resources based on beneficiation of its mineral resources, synthetic minerals and formulations. These contribute essential properties to customers' products and performance, including refractoriness, hardness, conductivity, opacity, durability, purity, lightness, filtration, absorption and repellency. Imerys is determined to develop responsibly, in particular by fostering the emergence of environmentally-friendly products and processes.

More comprehensive information about Imerys may be obtained from its website (www.imerys.com) under Regulated Information, particularly in its Registration Document filed with Autorité des marchés financiers on March 20, 2019 under number D.19-0175 (also available from the Autorité des marchés financiers website, www.amf-france.org). Imerys draws the attention of investors to chapter 4, "Risk Factors and Internal Control", of its Registration Document.

Disclaimer: This document contains projections and other forward-looking statements. Investors are cautioned that such projections and forward-looking statements are subject to various risks and uncertainties (many of which are difficult to predict and generally beyond the control of Imerys) that could cause actual results and developments to differ materially from those expressed or implied.

Analyst / Investor Relations:	Press contacts:
Vincent Gouley - +33 (0)1 4955 6469	Claire Garnier - +33 (0)1 4955 6427
finance@imerys.com	Philémon Tassel - +33 (0)6 3010 9611